Champions Oncology CSBR
NASDAQ CSBR
$4.71 -0.05 (-1.06%)
As of: Oct 23, 2026 · 3:47 PM EDT

Champions Oncology (CSBR) Return on Sales [ROS] (2010 - 2026)

Updated

Champions Oncology's Return on Sales [ROS] came in at -2.69% for fiscal Q1 2027 (quarter ended Jul 31, 2026), up 1.08 percentage points from -3.77% a year earlier and up 1.09 percentage points from the prior quarter.

Analysis

Champions Oncology (CSBR) Return on Sales [ROS] (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jul 31, 2026, Champions Oncology reported Return on Sales [ROS] of -1.68%, down 6.43 percentage points year-over-year; for FY2026 (ended Apr 30, 2026), it came in at -1.92%, down 9.91 percentage points from FY2025.

  • Return on Sales [ROS] carries a five-year change of -2.81 percentage points (FY2021 to FY2026).
  • Going back by fiscal year, Return on Sales [ROS] was 8.00% in FY2025 (+22.66 pp), -14.67% in FY2024 (-4.91 pp), -9.76% in FY2023 (-10.99 pp) and 1.24% in FY2022 (+0.34 pp).
  • The five-year range for quarterly Return on Sales [ROS] is -21.44% (fiscal Q3 2024) to 26.40% (fiscal Q3 2025).
  • Year-over-year, Return on Sales [ROS] increased in four of the last eight quarters, with an average year-over-year change of +2.99 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in fiscal Q3 2025 (a gain of 47.85 percentage points), and the weakest in fiscal Q3 2026 (a drop of 28.07 percentage points).
  • Business Quant data shows CSBR's Return on Sales [ROS] at -3.77% (Q4 2026), -1.67% (Q3 2026) and 1.23% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Iqvia Holdings 46.32 Bn 38.02 Bn 1.44 Bn 11.58%
2 Medpace Holdings 18.64 Bn 16.29 Bn 223.89 Mn 23.12%
3 Charles River Laboratories International 16.55 Bn 15.75 Bn 363.37 Mn 11.94%
4 Icon 14.51 Bn 11.62 Bn 479.29 Mn 6.68%
5 Fortrea Holdings 2.23 Bn 1.61 Bn 139.20 Mn 2.18%
6 Ginkgo Bioworks Holdings 615.67 Mn -146.42 Mn 18.44 Mn -290.47%
7 Evotec SE 539.84 Mn -1.07 Bn - -
8 Champions Oncology 65.46 Mn 40.54 Mn 7.70 Mn -2.69%
9 MindWalk Holdings 53.84 Mn 17.49 Mn 1.61 Mn -159.86%
10 Natural Alternatives International 7.11 Mn -20.97 Mn 1.73 Mn -38.18%
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 -2.69%
Apr 30, 2026 -3.77%
Jan 31, 2026 -1.67%
Oct 31, 2025 1.23%
Jul 31, 2025 -3.77%
Apr 30, 2025 -16.24%
Jan 31, 2025 26.40%
Oct 31, 2024 5.43%
Jul 31, 2024 9.45%
Apr 30, 2024 -1.94%
Jan 31, 2024 -21.44%
Oct 31, 2023 -16.89%
Jul 31, 2023 -20.32%
Apr 30, 2023 -19.29%
Jan 31, 2023 -19.24%
Oct 31, 2022 0.05%
Jul 31, 2022 -2.07%
Apr 30, 2022 -2.42%
Jan 31, 2022 6.29%
Oct 31, 2021 2.23%
API Access

Champions Oncology Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CSBR&period=max&api_key=YOUR_API_KEY